How to Buy Arvinas Stock
Arvinas Inc
Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identifying, advancing, and marketing innovative therapies designed to eliminate disease-causing proteins.
Arvinas stock last closed at $8.29, down 0.24% from the previous day, and has increased 7.38% in one year. It has overperformed other stocks in the Biotechnology industry by 0.29 percentage points. Arvinas stock is currently +18.94% from its 52-week low of $6.97, and -42.87% from its 52-week high of $14.51.
At the moment, there are 65.39M ARVN shares outstanding. The market capitalization of ARVN is $542.05M. In the past 24 hours, 1.78M ARVN shares were traded.
How to Buy Arvinas Stock
Not sure how to invest in Arvinas stock? Here's how.
- Figure out where to buy Arvinas stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you figure out where to buy Arvinas stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Select your method of payment and add your details.
- Research Arvinas stock: The Arvinas ticker symbol is ARVN. Is Arvinas stock a good investment? Should you buy shares of ARVN? How do ARVN's underlying business fundamentals look? Do top analysts think Arvinas is a good buy? Why has ARVN's stock price moved recently? (Hint: Our stock research tools can help you figure out if ARVN is a good stock to buy).
- Execute your ARVN buy order: Decide if you will purchase ARVN shares at the current market price or use a limit order to buy ARVN shares at a given price.
- Monitor your investment in ARVN: Create a watchlist to the latest updates on your investment in Arvinas shares.
Step 1: Figure out where to buy Arvinas stock
You need a brokerage account in order to access the NASDAQ market and buy ARVN stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal information so you can invest in ARVN today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've filled out your info on the best stock investing app, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing funds into your brokerage account.
Step 4: Research Arvinas stock
Once you have chosen the best place to buy Arvinas stock, it's important to research their stock prior to buying, so you actually comprehend the risk and opportunity.
Arvinas shares data
Arvinas Due Diligence Score
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ARVN's stock page.
Is ARVN stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ARVN's true value.
Using relative valuations methods:
- ARVN could be overvalued based on its P/E ratio of 30.7x, relative to Biotechnology industry P/E ratio of 9.29x
- ARVN may be undervalued based on its P/B ratio of 0.96x, relative to Biotechnology industry P/B ratio of 5.28x
You can do additional valuation research on ARVN's stock here.
How do ARVN Financials look?
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the ARVN balance sheet.
- There are more short-term assets than short-term liabilities on the ARVN balance sheet.
- ARVN has $567.90M in cash and short term investments. This is sufficient to cover its annual cash burn of $208.80M.
- ARVN has cash burn of 208800000. It has enough cash and short-term investments to cover this for at least one year.
- ARVN has a low debt to equity ratio of 0.2.
- ARVN profit margin has gone up from -19.5% to 2.9% in the past year.
Failed Financial Due Diligence Checks:
- Total ARVN debt is higher than 5 years ago, relative to shareholder equity.
Is Arvinas stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Equities analysts who research ARVN, the consensus analyst rating on Arvinas is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Latest ARVN Analyst Upgrades/Downgrades
Sudan Loganathan, a top 14% analyst from Stephens & Co. reiterates ARVN with a strong buy rating and maintains their ARVN price target from $18.00 to $18.00, on Jun 3, 2026.
Etzer Darout, a top 2% analyst from Barclays maintains ARVN with a strong buy rating and raises their ARVN price target from $18.00 to $20.00, on May 13, 2026.
Barclays's Etzer Darout raised their price target on Arvinas (NASDAQ: ARVN) by 11.1% from $18 to $20 on 2026/05/13. The analyst maintained their Strong Buy rating on the stock.
Arvinas reported its Q1 2026 earnings.
Darout called the news of the company's business partnership with Veppanu "encouraging."
In addition, the analyst noted that Arvinas' early pipeline remains strong.
Earnings Report
For Q1 2026, Arvinas reported:
- Loss per share $0.90, which beat the Zacks Consensus Estimate of $(0.95) but missed Q1 2025’s $1.14.
- Revenue of $15.6M, which missed the Zacks Consensus Estimate by 0.74% and, by 91.74%, Q1 2025’s $188.8M.
Management did not provide EPS and revenue guidance in its press release.
President & CEO Randy Teel, Ph.D. commented: “The approval of VEPPANU is a defining achievement for Arvinas and reflects the culmination of more than a decade of focused work to translate our PROTAC science into our first approved therapy.
“I’m proud to lead an organization advancing an industry-leading portfolio of degraders - one that has now joined the short list of those able to bring a new therapeutic modality from discovery to approval.
“As we move through the remainder of the year, our focus is on delivering key data and clinical milestones that we believe will further validate our approach and clearly distinguish our programs in an increasingly competitive environment.”
You can dig deeper into what analysts are saying on the Arvinas stock forecast page.
Metrics for Advanced ARVN Traders
Is ARVN Making Money?
Last year, ARVN revenue was $316.70M. During the past 5 year, ARVN's revenue has increased by 66.28% per year. This was faster than the Biotechnology industry average of 24.78%.
You can analyze ARVN's earnings and revenue performance here.
Who is buying/selling ARVN?
Over the last 12 months, executives and large shareholders at ARVN have sold more shares than they have bought.
Andrew Saik, Chief Financial Officer of ARVN, was the latest ARVN insider to sell. They sold $46,473.66 worth of ARVN shares on Jun 24, 2026.
Dig into more about who owns ARVN shares here.
Does ARVN provide a stable income stream?
No, Arvinas doesn't provide an income stream by paying out dividends.
ARVN Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your ARVN buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.
Press the Open Trade button and your broker will execute your order.
If you need more help with investing in stocks on eToro, watch the helpful video below:
Step 6: Monitor your investment in ARVN
Now that you own some ARVN shares, you'll want to keep up with your company.
Make a watchlist to track the latest developments regarding your ARVN stock.
ARVN Feed
How to Buy Stock in Arvinas
To summarize, here are the 6 steps you need to take to buy Arvinas stock right now:
- Figure out where to buy Arvinas stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Research Arvinas stock
- Execute your ARVN buy order
- Monitor your investment in ARVN
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your new investment in Arvinas, get started below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.